Use Able AI chat for product recommendations

Osteocalcin/OCN Polyclonal antibody

Osteocalcin/OCN Polyclonal Antibody for IHC, IF/ICC, FC (Intra), ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, FC (Intra), ELISA

BGLAP, Osteocalcin, BGP, Bone Gla protein, Gamma-carboxyglutamic acid-containing protein

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
CoraLite® Plus 488
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for Osteocalcin/OCN in ?

Tested Applications

Positive IHC detected inhuman osteosarcoma tissue, mouse lung tissue, rat lung tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inNIH/3T3 cells
Positive FC (Intra) detected inU2OS cells

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

16157-1-AP targets Osteocalcin/OCN in WB, IHC, IF/ICC, FC (Intra), ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name bone gamma-carboxyglutamate (gla) protein
Calculated Molecular Weight 11 kDa
GenBank Accession NumberNM_199173
Gene Symbol Osteocalcin
Gene ID (NCBI) 632
RRIDAB_2878225
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP02818
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
FC protocol for Osteocalcin/OCN antibody 16157-1-APDownload protocol
IF protocol for Osteocalcin/OCN antibody 16157-1-APDownload protocol
IHC protocol for Osteocalcin/OCN antibody 16157-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The Osteocalcin/OCN Polyclonal antibody (Cat# 16157-1-AP) has 47 citations across journals including Nature Communications, Bioactive Materials, Advanced Science, Acta Biomaterialia, Cell Death & Disease, Materials Today Bio, FASEB Journal, and Bone. Research fields span bone regeneration and osteogenesis, osteoporosis, periodontitis, bone defect repair, osteosarcoma, vascular calcification, diabetic bone loss, and ferroptosis.

SpeciesApplicationTitle

Bioact Mater

Intelligent responsive alloy scaffold temporally regulates the immune-osteogenic axis for the treatment of infectious bone defects.

Authors - Dong Ruan
ratWB

Bioact Mater

A mitochondria-targeted nanoantioxidant restores alveolar bone homeostasis in periodontitis by quenching ROS and suppressing the cGAS-STING pathway.

Authors - Ning Huang
humanIF

Nat Commun

Dnmt1 determines bone length by regulating energy metabolism of growth plate chondrocytes.

Authors - Yuta Yanagihara
mouseWB

Nat Commun

Intelligence-responsive wettability switch coating on magnesium implants for treating osteoporotic fracture.

Authors - Guobin Qi
ratIF

J Nanobiotechnology

Piezoelectric heterojunction/polyetherketoneketone composite with enhanced sonodynamic efficacy and nanozyme activities for anti-infection and encouraging neurovascular ossification.

Authors - Shangyu Xie
mouseWB,IHC

Adv Sci (Weinh)

CGRP Enhances the Regeneration of Bone Defects by Regulating Bone Marrow Mesenchymal Stem Cells Through Promoting ANGPTL4 Secretion by Bone Blood Vessels.

Authors - Qiong Lu
Loading...
||
New chat

Able™

正在加载,请稍候...